The Scotts Miracle-Gro (SMG) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Apr, 2026Executive summary
Achieved leverage of 3.71x debt to EBITDA, first time below 4x in four years, with Q2 2026 net sales of $1.46 billion, up 5% year-over-year, and completed Hawthorne divestiture.
Free cash flow, EBITDA, and EPS exceeded expectations in the first half of fiscal 2026, with adjusted EBITDA at $437.4 million and adjusted diluted EPS at $4.53.
Initiating a multi-year share repurchase program, aiming to buy back at least a third of outstanding shares.
Launched SMG 2.0, targeting $1 billion incremental sales by 2030, gross margin near 40%, and EBITDA over $1 billion.
Hired a new Chief Brand Officer and expanded executive roles to drive innovation and growth.
Financial highlights
Q2 net sales increased 5% to $1.46 billion; first six months net sales up 3% year-over-year.
Branded product sales up 8% in the first half, offsetting declines in mulch and non-branded products.
E-commerce POS dollars up 22% year-to-date, with growth in every category and customer.
GAAP gross margin rate for Q2 was 41.8%, up 280 basis points; adjusted gross margin up 240 basis points year-over-year.
Q2 adjusted EBITDA was $437.4 million, up from $401.6 million last year; year-to-date adjusted EBITDA $440.2 million.
Q2 GAAP net income from continuing operations was $263.3 million ($4.46/share), up from $220.7 million ($3.78/share) last year; adjusted diluted EPS at $4.53.
Year-to-date free cash flow improved by over $100 million; fiscal 2026 free cash flow guidance set at $275 million.
Outlook and guidance
Reaffirmed fiscal 2026 guidance for net sales growth, gross margin expansion, and leverage reduction; U.S. Consumer net sales expected to grow low single digits.
Adjusted gross margin rate projected at least 32%; adjusted EPS from continuing operations expected between $4.15 and $4.35.
Adjusted EBITDA anticipated to grow mid-single digits; free cash flow target set at $275 million; leverage ratio expected in the high 3s.
Most commodity costs for the year are locked; contingency plans in place for supply chain risks.
Fiscal 2027 outlook remains uncertain due to commodity volatility from the Iran conflict; pricing actions will be used if necessary.
Latest events from The Scotts Miracle-Gro
- Q1 margin gains, Hawthorne divestiture, and $500M buyback support a strong 2026 outlook.SMG
Q1 202620 Apr 2026 - All proposals passed as the company reported strong financials and outlined growth strategies.SMG
AGM 202612 Apr 2026 - Margin expansion, $150M supply chain savings, and 3% sales growth drive future value.SMG
Investor Day 20243 Feb 2026 - Q3 sales and margins surged, with net income and guidance both sharply improved.SMG
Q3 20242 Feb 2026 - Margin gains, innovation, and free cash flow drive a positive outlook despite topline shifts.SMG
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - 20% EBITDA growth, strong cash flow, and margin gains signal a robust turnaround.SMG
Q4 202416 Jan 2026 - Financial turnaround, board refreshment, and all proposals approved amid strong shareholder support.SMG
AGM 20259 Jan 2026 - Q1 sales and margin gains, U.S. Consumer up 11%, Hawthorne down 35%, outlook reaffirmed.SMG
Q1 20259 Jan 2026 - Strong margin and EPS growth in 2025, with further gains and buybacks expected in 2026.SMG
Q4 202529 Dec 2025